Immersion Medical Introduces First Touch Feedback Hysteroscopy Training Simulator.

Business Editors/Health/Medical Writers

American Association of Gynecologic Laparoscopists Annual Meeting

LAS VEGAS--(BUSINESS WIRE)--Nov. 19, 2003

AccuTouch(R) Hysteroscopy Simulator Provides Doctors

with Vital Women's Health Training

Immersion Medical, a wholly owned subsidiary of Immersion Corporation (NASDAQ:IMMR), today introduced its beta AccuTouch Hysteroscopy simulator. This simulator is one of the first commercial gynecological simulators that specifically incorporates training with a hysteroscope while simulating a specific procedure.

The new hysteroscopy simulator with Immersion's proprietary haptic-feedback technology realistically recreates this procedure on a virtual female patient. Complete with two new modules involving aspects of basic hysteroscopy and myomectomy, doctors can practice hysteroscopy and accompanying procedures such as tumor removal. The high-fidelity hardware and software enable a physician to sense changes in texture, resistance and density - making use of life-like cues that improve control, performance and results.

According to the American Cancer Society, in 2002 more than 80,000 women were diagnosed with a gynecologic cancer, making it the fourth most common cancer group in American women. However, according to the American Association of Gynecologic Laparoscopists, only 15 percent of U.S. gynecologists today perform office hysterososcopy, partly because appropriate tools became available only in the last decade.

"Abnormal bleeding in women is very common today, and sometimes caused by cancer," stated Leroy Heinrichs, M.D., Director of Surgical Simulation at Stanford University. "The AccuTouch Hysteroscopy simulator is therefore critical to help increase the competence levels for conducting diagnostic and operative gynecological procedures that are safe and comfortable for the patient."

The AccuTouch Hysteroscopy simulator is the culmination of work initiated in 1998 with the help of Stanford University/NASA's National Biocomputation Center and Dr. Heinrichs, who works at Stanford University Medical Media and Information Technologies center (SUMMIT) and who also helped secure a grant from the National Institute of Child Health and Human Development to fund the project. For the past year, Immersion Medical and the GYNECARE Worldwide division of ETHICON, INC. worked together to develop the hardware while GYNECARE provided clinical expertise for the software development.

Immersion Medical is a leader in the medical simulation market with hundreds of medical simulators in top hospitals nationwide. Immersion Medical uses its comprehensive suite of patented intellectual property to develop touch technology that enriches the user experience by mimicking the look, sound and feel of performing minimally invasive procedures.

"We recognized a need for more women's health training devices to assist healthcare professionals in becoming more proficient in gynecological procedures," said Bill Lewandowski, Vice President of Simulation Systems for Immersion Medical. "Medical simulators are the best tools to ensure doctors are properly trained and that these procedures are safe and comfortable. With less discomfort, women may be more likely to come in for screening on a regular basis."

Hysteroscopy is a procedure that involves looking into the cavity of the uterus with a thin optical instrument, or hysteroscope, to help evaluate patients with various gynecologic conditions. During the procedure, the physician can introduce various tools alongside the hysteroscope to correct uterine abnormalities, remove tumors, and even remove the entire uterine lining.

Interested parties can contact Immersion Medical directly at 301-984-3706 or email to [e-mail].

About Immersion Medical

Immersion Medical designs, manufactures and markets computer-based medical training simulation systems worldwide. The systems integrate proprietary computer software and tactile feedback robotics to create highly realistic medical procedure simulations that help train doctors. The company's four key product lines are the CathSim(R) Vascular Access Simulator, the AccuTouch(R) Endoscopy Simulator, the AccuTouch Endovascular Simulator, and the AccuTouch Laparoscopic Simulator.

About Immersion (www.immersion.com)

Founded in 1993, Immersion Corporation is a recognized leader in developing, licensing and marketing digital touch technology and products. Bringing value to markets where man-machine interaction needs to be made more compelling, safer or productive, Immersion helps its partners broaden market reach by making the use of touch feedback as critical a user experience as sight and sound. Immersion's technology is deployed across personal computing, mobile, entertainment, medical training, automotive and three-dimensional simulation markets. Immersion and its wholly-owned subsidiaries hold more than 200 issued patents worldwide.

Forward Looking Statements

This press release contains "forward-looking statements" that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause the results of Immersion Corporation and its consolidated subsidiaries to differ materially from those expressed or implied by such forward-looking statements.

All statements, other than the statements of historical fact, are statements that may be deemed forward-looking statements, including any projections of earnings, revenues, or other financial matters; any statements of the plans, strategies, and objectives of management for future operations; any statements concerning the development and performance of touch-enabled medical training technology or consumer and market acceptance of force feedback products in general, future development of force feedback products; proposed products or services; any statements regarding future economic conditions or performance; statements of belief and any statement or assumptions underlying any of the foregoing. Immersion's actual results might differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with Immersion's business which include, but are not limited to, delay in or failure to achieve commercial demand for Immersion's products or a delay in or failure to achieve the acceptance of force feedback as a critical user experience.

For a more detailed discussion of these factors, and other factors that could cause the Company's actual results to vary materially, interested parties should review the risk factors listed in the Company's most current Form 10-K and the Forms 10-Q for the Company's current fiscal year, which are on file with the U.S. Securities and Exchange Commission. The forward-looking statements in this press release reflect the Company's beliefs and predictions as of the date of this release. The Company disclaims any obligation to update these forward-looking statements as a result of financial, business or any other developments occurring after the date of this release.

AccuTouch is a registered trademark of Immersion Corporation.